Form
Filing Date
Sep 29, 2023
Document Date
Sep 27, 2023
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
AN2 Therapeutics, Inc
Issuer
AN2 THERAPEUTICS, INC.
Filer
Adjuvant Global Health Technology Fund, L.P.